Indo Amines Past Earnings Performance
Past criteria checks 4/6
Indo Amines has been growing earnings at an average annual rate of 18.3%, while the Chemicals industry saw earnings growing at 16% annually. Revenues have been growing at an average rate of 17.1% per year. Indo Amines's return on equity is 16.2%, and it has net margins of 4.5%.
Key information
18.3%
Earnings growth rate
17.7%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 17.1% |
| Return on equity | 16.2% |
| Net Margin | 4.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Indo Amines Limited's (NSE:INDOAMIN) Earnings Are Not Doing Enough For Some Investors
Jun 28
Indo Amines Limited (NSE:INDOAMIN) Might Not Be As Mispriced As It Looks After Plunging 25%
Mar 09Does Indo Amines (NSE:INDOAMIN) Have A Healthy Balance Sheet?
Feb 18Should You Be Adding Indo Amines (NSE:INDOAMIN) To Your Watchlist Today?
Jan 31Even With A 33% Surge, Cautious Investors Are Not Rewarding Indo Amines Limited's (NSE:INDOAMIN) Performance Completely
Jan 03A Look Into Indo Amines' (NSE:INDOAMIN) Impressive Returns On Capital
Dec 07Pinning Down Indo Amines Limited's (NSE:INDOAMIN) P/E Is Difficult Right Now
Jun 14Revenue & Expenses Breakdown
How Indo Amines makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 9,436 | 428 | 447 | 0 |
| 31 Dec 23 | 9,250 | 504 | 443 | 0 |
| 30 Sep 23 | 9,422 | 512 | 433 | 0 |
| 30 Jun 23 | 9,304 | 445 | 399 | 0 |
| 31 Mar 23 | 9,450 | 404 | 399 | 0 |
| 31 Dec 22 | 9,242 | 260 | 369 | 0 |
| 30 Sep 22 | 9,247 | 253 | 356 | 0 |
| 30 Jun 22 | 8,672 | 244 | 340 | 0 |
| 31 Mar 22 | 7,860 | 230 | 333 | 0 |
| 31 Dec 21 | 7,285 | 368 | 320 | 0 |
| 30 Sep 21 | 6,592 | 395 | 312 | 0 |
| 30 Jun 21 | 6,123 | 419 | 312 | 0 |
| 31 Mar 21 | 5,405 | 375 | 291 | 0 |
| 31 Dec 20 | 5,070 | 229 | 304 | 0 |
| 30 Sep 20 | 4,786 | 128 | 299 | 0 |
| 30 Jun 20 | 4,538 | 108 | 271 | 0 |
| 31 Mar 20 | 4,787 | 128 | 297 | 0 |
| 31 Dec 19 | 4,947 | 181 | 288 | 0 |
| 30 Sep 19 | 5,051 | 238 | 276 | 0 |
| 30 Jun 19 | 5,146 | 252 | 268 | 0 |
| 31 Mar 19 | 5,281 | 252 | 271 | 0 |
| 31 Mar 18 | 3,553 | 160 | 183 | 0 |
| 31 Mar 17 | 2,845 | 162 | 150 | 0 |
| 31 Mar 16 | 2,526 | 91 | 125 | 0 |
| 31 Dec 15 | 2,426 | 97 | 289 | 5 |
| 30 Sep 15 | 2,413 | 88 | 282 | 5 |
| 30 Jun 15 | 2,383 | 67 | 281 | 5 |
| 31 Mar 15 | 2,340 | 53 | 113 | 0 |
| 31 Dec 14 | 2,364 | 38 | 145 | 0 |
| 30 Sep 14 | 2,466 | 53 | 197 | 0 |
| 30 Jun 14 | 2,329 | 60 | 185 | 0 |
| 31 Mar 14 | 2,206 | 58 | 268 | 4 |
| 31 Dec 13 | 2,114 | 55 | 161 | 0 |
| 30 Sep 13 | 2,042 | 52 | 64 | 0 |
Quality Earnings: INDOAMIN has high quality earnings.
Growing Profit Margin: INDOAMIN's current net profit margins (4.5%) are higher than last year (4.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INDOAMIN's earnings have grown by 18.3% per year over the past 5 years.
Accelerating Growth: INDOAMIN's earnings growth over the past year (5.9%) is below its 5-year average (18.3% per year).
Earnings vs Industry: INDOAMIN earnings growth over the past year (5.9%) exceeded the Chemicals industry -0.2%.
Return on Equity
High ROE: INDOAMIN's Return on Equity (16.2%) is considered low.